title: Lead decreases parasitemia and enhances survival of Plasmodium berghei-infected mice.
abstract: Malaria, a disease accounting for more than one million deaths per year, is caused by intraerythrocytic growth of Plasmodia. Parasitemia may be blunted by suicidal erythrocyte death or eryptosis, which is characterized by cell shrinkage and phosphatidylserine exposure. Triggers of eryptosis include lead nitrate (Pb(NO3)2). As shown here, Pb(NO3)2 (> or = 10 microM) increased phosphatidylserine exposure of Plasmodium falciparum-infected human erythrocytes, an effect significantly more marked than in noninfected cells. Pb(NO3)2 treatment accelerated the clearance of erythrocytes from circulating blood. Parasitemia in Plasmodium berghei-infected mice was significantly decreased and mouse survival significantly enhanced by 100 microM Pb(NO3)2 (20 ppm) in drinking water. The treatment significantly increased reticulocyte number but did not significantly decrease erythrocyte number in noninfected mice and in infected animals mainly triggered the disappearance of P. berghei harbouring erythrocytes. In conclusion, Pb(NO3)2 accelerates eryptosis and subsequent clearance of infected erythrocytes and thus favourably influences the course of malaria.
authors: Department of Physiology, University of Tübingen, Gmelinstr. 5, D-72076 Tübingen, Germany.
authors: Saisudha
authors: S
authors: Koka
authors: Stephan M
authors: SM
authors: Huber
authors: Krishna M
authors: KM
authors: Boini
authors: Camelia
authors: C
authors: Lang
authors: Michael
authors: M
authors: Föller
authors: Florian
authors: F
authors: Lang
mesh_terms: D000818:Animals; D004305:Dose-Response Relationship, Drug; D004906:Erythrocyte Count; D004912:Erythrocytes / Q000166:cytology / Q000187:drug effects / Q000469:parasitology; D005434:Flow Cytometry; D006801:Humans; D007854:Lead / Q000494:pharmacology* / Q000627:therapeutic use; D008288:Malaria / Q000097:blood / Q000469:parasitology / Q000517:prevention & control*; D051379:Mice; D009566:Nitrates / Q000494:pharmacology* / Q000627:therapeutic use; D018512:Parasitemia / Q000469:parasitology / Q000517:prevention & control*; D010962:Plasmodium berghei / Q000187:drug effects* / Q000254:growth & development; D010963:Plasmodium falciparum / Q000187:drug effects / Q000254:growth & development; D012156:Reticulocytes / Q000166:cytology / Q000187:drug effects; D016019:Survival Analysis; D013997:Time Factors
chemical_list: D009566:Nitrates; D007854:Lead; C017461:lead nitrate